Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis. [electronic resource]
Producer: 20020918Description: 871-80 p. digitalISSN:- 0022-3565
- Animals
- Astrocytoma -- metabolism
- Brain Neoplasms -- metabolism
- Calcium -- metabolism
- Chlorides -- metabolism
- Cilia -- drug effects
- Cystic Fibrosis -- drug therapy
- Deoxycytosine Nucleotides -- pharmacology
- Epithelial Cells -- drug effects
- Humans
- In Situ Hybridization
- In Vitro Techniques
- Indicators and Reagents
- Macaca mulatta
- Mucins -- metabolism
- Mucociliary Clearance -- drug effects
- Ophthalmic Solutions -- pharmacology
- Polyphosphates
- Purinergic P2 Receptor Agonists
- Receptors, Purinergic P2 -- biosynthesis
- Receptors, Purinergic P2Y2
- Reverse Transcriptase Polymerase Chain Reaction
- Sheep
- Tumor Cells, Cultured
- Uracil Nucleotides
- Uridine -- analogs & derivatives
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.